The Behavioral and Psychological Symptoms of Dementia in Down Syndrome scale (BPSD-DS II): optimization and further validation

Manuscript Number: 

20-1427R3

Author(s): 
Bessy Benejam, Gonny Beugelsdijk, Vincent A. Boxelaar, Angelo Carfi, Antonia MW Coppus, Peter P. De Deyn, Alain D. Dekker, Ségolène Falquero, Roelie Fopma, Juan Fortea, Henk Groen, Hepie Henstra, Marloes Hermelink, Anneke Loonstra-de Jong, Graziano Onder, Marjo Oosterik, Anne-Sophie Rebillat, Silvia Sacco, Mieke Schippers, Martine Scholten-Kuiper, Marleen Tollenaere, Aurora M. Ulgiati, Silvia Valldeneu, Debby Van Dam, Liesbeth Willems, Judith Willink-Vos, Lisa de Ruiter, Antonella di Paola

Disclosures

Bessy Benejam

  • Nothing to Disclose

Gonny Beugelsdijk

  • Nothing to Disclose

Vincent A. Boxelaar

  • Nothing to Disclose

Angelo Carfi

  • Nothing to Disclose

Antonia MW Coppus

  • Nothing to Disclose

Peter P. De Deyn

  • Nothing to Disclose

Lisa de Ruiter

  • Nothing to Disclose

Alain D. Dekker

  • Nothing to Disclose

Antonella di Paola

  • Nothing to Disclose

Ségolène Falquero

  • Nothing to Disclose

Roelie Fopma

  • Nothing to Disclose

Juan Fortea

  • Consulting Fees:
    Lundbeck; Novartis; AC Inmune
    Lecture Fees:
    Scientific talks not related to the sponsors´s products. Talks for Novartis; Biogen; Novonordisk; Esteve.

Henk Groen

  • Nothing to Disclose

Hepie Henstra

  • Nothing to Disclose

Marloes Hermelink

  • Nothing to Disclose

Anneke Loonstra-de Jong

  • Nothing to Disclose

Graziano Onder

  • Nothing to Disclose

Marjo Oosterik

  • Nothing to Disclose

Anne-Sophie Rebillat

  • Nothing to Disclose

Silvia Sacco

  • Nothing to Disclose

Mieke Schippers

  • Nothing to Disclose

Martine Scholten-Kuiper

  • Nothing to Disclose

Marleen Tollenaere

  • Nothing to Disclose

Aurora M. Ulgiati

  • Nothing to Disclose

Silvia Valldeneu

  • Nothing to Disclose

Debby Van Dam

  • Nothing to Disclose

Liesbeth Willems

  • Nothing to Disclose

Judith Willink-Vos

  • Nothing to Disclose